Frank Scherbaum, founder and managing director of Oxington GmbH

Frank Scherbaum

Founder & Managing Director, Oxington GmbH · Berlin

Frank Scherbaum is an entrepreneur and market access expert from Berlin. As founder and managing director of Oxington GmbH, he combines many years of experience in medical technology and reimbursement strategies with the development of digital knowledge and software solutions.

Focus areas

Career

Since 2015

Founder and Managing Director · Oxington GmbH, Berlin

Built and leads Oxington GmbH, focusing on market access consulting and software development for life science, medical technology and healthcare. Under the Oxington umbrella, RECIN was created – a knowledge network for organizations.

2021 – 2026

Head of Market Access DACH/GSA · Insulet

Responsible for the market access of diabetes technologies in the DACH/GSA region, including the automated insulin delivery system Omnipod 5 – from reimbursement strategy to anchoring in routine care.

Earlier positions

Olympus · Boston Scientific · AMS · Helios

Leadership and expert roles in medical technology and hospital management, focusing on market access, reimbursement and the launch of complex medical devices. Before that, he gained experience in the digital economy, including at eBay and AOL.

Ongoing

Master's degree with research on RECIN

Part-time master's programme; the ongoing research examines knowledge networks in organizations and feeds directly into the further development of RECIN as a product of Oxington GmbH.

How he works

Frank's work is analytical, evidence-based and consistent. He translates scientific findings into viable strategies, realistically evaluates care models and brings products to market without ignoring the logic of clinics, health insurers and healthcare policy. Having trained in software development alongside his commercial education still shapes the way he works – he thinks strategy and technical implementation together. His professional base is Berlin.

Get in touch